Index by author

February 1, 2022; Volume 63,Issue 2

  1. Kang, Choong Mo

    1. An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-Therapy
      An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy
      Ronnie C. Mease, Choong Mo Kang, Vivek Kumar, Sangeeta Ray Banerjee, Il Minn, Mary Brummet, Kathleen L. Gabrielson, Yutian Feng, Andrew Park, Ana P. Kiess, George Sgouros, Ganesan Vaidyanathan, Michael R. Zalutsky and Martin G. Pomper
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 259-267; DOI: https://doi.org/10.2967/jnumed.121.262098

  2. Kayani, Irfan

    1. Evolution of <sup>18</sup>F-FDG PET/CT Findings in Patients After COVID-19: An Initial Investigation
      Open Access
      Evolution of 18F-FDG PET/CT Findings in Patients After COVID-19: An Initial Investigation
      Andrew Thornton, Francesco Fraioli, Simon Wan, Helen S. Garthwaite, Balaji Ganeshan, Robert I. Shortman, Raymond Endozo, Stefan Vöö, Irfan Kayani, Deena Neriman, Leon Menezes, Jamshed Bomanji, Toby Hilllman, Melissa Heightman, Joanna C. Porter and Ashley M. Groves
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 270-273; DOI: https://doi.org/10.2967/jnumed.121.262296

  3. Keidar, Zohar

    1. Diagnostic Performance and Clinical Impact of <sup>68</sup>Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study)
      Open Access
      Diagnostic Performance and Clinical Impact of 68Ga-PSMA-11 PET/CT Imaging in Early Relapsed Prostate Cancer After Radical Therapy: A Prospective Multicenter Study (IAEA-PSMA Study)
      Juliano J. Cerci, Stefano Fanti, Enrique E. Lobato, Jolanta Kunikowska, Omar Alonso, Sevastian Medina, Fuad Novruzov, Thabo Lengana, Carlos Granados, Rakesh Kumar, Venkatesh Rangarajan, Akram Al-Ibraheem, Mukbil Hourani, Nor S. Ali, Azra Ahmad, Zohar Keidar, Ozlem Küçük, Umut Elboga, Mateos Bogoni and Diana Paez
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 240-247; DOI: https://doi.org/10.2967/jnumed.120.261886

  4. Kennedy, Richard E.

    1. Dynamic Amyloid PET: Relationships to <sup>18</sup>F-Flortaucipir Tau PET Measures
      Dynamic Amyloid PET: Relationships to 18F-Flortaucipir Tau PET Measures
      Fabio Raman, Yu-Hua Dean Fang, Sameera Grandhi, Charles F. Murchison, Richard E. Kennedy, John C. Morris, Parinaz Massoumzadeh, Tammie Benzinger, Erik D. Roberson and Jonathan McConathy
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 287-293; DOI: https://doi.org/10.2967/jnumed.120.254490

  5. Kesner, Adam L

    1. Commercially Competitive Vendor-Agnostic Image Reconstruction Could Be a Leap Forward for PET Harmonization
      Adam L Kesner
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 323-324; DOI: https://doi.org/10.2967/jnumed.121.263421

  6. Khodaii, Javad

    1. Relative Strengths of Three Linearizations of Receptor Availability: Saturation, Inhibition, and Occupancy Plots
      Relative Strengths of Three Linearizations of Receptor Availability: Saturation, Inhibition, and Occupancy Plots
      Javad Khodaii, Mostafa Araj-Khodaei, Manouchehr S. Vafaee, Dean F. Wong and Albert Gjedde
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 294-301; DOI: https://doi.org/10.2967/jnumed.117.204453

  7. Kiess, Ana P.

    1. An Improved <sup>211</sup>At-Labeled Agent for PSMA-Targeted α-Therapy
      An Improved 211At-Labeled Agent for PSMA-Targeted α-Therapy
      Ronnie C. Mease, Choong Mo Kang, Vivek Kumar, Sangeeta Ray Banerjee, Il Minn, Mary Brummet, Kathleen L. Gabrielson, Yutian Feng, Andrew Park, Ana P. Kiess, George Sgouros, Ganesan Vaidyanathan, Michael R. Zalutsky and Martin G. Pomper
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 259-267; DOI: https://doi.org/10.2967/jnumed.121.262098

  8. Kind, Felix

    1. Kidney Doses in <sup>177</sup>Lu-Based Radioligand Therapy in Prostate Cancer: Is Dose Estimation Based on Reduced Dosimetry Measurements Feasible?
      Kidney Doses in 177Lu-Based Radioligand Therapy in Prostate Cancer: Is Dose Estimation Based on Reduced Dosimetry Measurements Feasible?
      Michael Mix, Tobias Renaud, Felix Kind, Ursula Nemer, Elham Yousetzadeh-Nowsha, Tumelo C.G. Moalosi, Aymen M. Ormrane, Philipp T. Meyer and Juri Ruf
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 253-258; DOI: https://doi.org/10.2967/jnumed.121.262245

  9. Kong, Grace

    1. Efficacy and Safety of <sup>177</sup>Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
      Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
      Lamiaa Zidan, Amir Iravani, Kira Oleinikov, Simona Ben-Haim, David J. Gross, Amichay Meirovitz, Ophra Maimon, Tim Akhurst, Michael Michael, Rodney J. Hicks, Simona Grozinsky-Glasberg and Grace Kong
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 218-225; DOI: https://doi.org/10.2967/jnumed.120.260760

  10. Kratochwil, Clemens

    1. Tumor Sink Effect in <sup>68</sup>Ga-PSMA-11 PET: Myth or Reality?
      Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?
      Andrei Gafita, Hui Wang, Andrew Robertson, Wesley R. Armstrong, Raphael Zaum, Manuel Weber, Farid Yagubbayli, Clemens Kratochwil, Tristan R. Grogan, Kathleen Nguyen, Fernando Navarro, Rouzbeh Esfandiari, Isabel Rauscher, Bjoern Menze, David Elashoff, Ebrahim S. Delpassand, Ken Herrmann, Johannes Czernin, Michael S. Hofman, Jeremie Calais, Wolfgang P. Fendler and Matthias Eiber
      Journal of Nuclear Medicine February 1, 2022, 63 (2) 226-232; DOI: https://doi.org/10.2967/jnumed.121.261906
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue